Clinical Trials List
2022-12-23 - 2026-12-31
Phase I/II
Not yet recruiting2
Recruiting3
ICD-10C7A.1
Malignant poorly differentiated neuroendocrine tumors
ICD-10C7A.8
Other malignant neuroendocrine tumors
ICD-10C7B.09
Secondary carcinoid tumors of other sites
ICD-10C7B.1
Secondary Merkel cell carcinoma
ICD-10C7B.8
Other secondary neuroendocrine tumors
ICD-10C80.0
Disseminated malignant neoplasm, unspecified
ICD-10D3A.8
Other benign neuroendocrine tumors
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9199.0
Disseminated malignant neoplasm
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Yu-Min Liao Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Chen-Yuan Lin Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chih-Hung Hsu Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- Hsin-Yu Liu Division of Hematology & Oncology
- 吳宗哲 Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chun-Liang Chou Division of Thoracic Medicine
- Jia-Ruey Tsai Division of Thoracic Medicine
- Chi-Li Chung Division of Thoracic Medicine
- Mei-Chuan Chen Division of Thoracic Medicine
- Shang-Fu Hsu Division of Thoracic Medicine
- Chao-Hua Chiu Division of Thoracic Medicine
- Cheng-I Hsieh Division of Thoracic Medicine
- Han-Pin Kuo Division of Thoracic Medicine
- Kai-Ling Lee Division of Thoracic Medicine
- Huan-Tze Lin Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- 顏志傑 Division of Hematology & Oncology
- 劉奕廷 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tsai-Sheng Yang Division of Hematology & Oncology
- Ming-Mo Hou Division of Hematology & Oncology
- Hung-Ming Wang Division of Hematology & Oncology
- 黃振洋 Division of Hematology & Oncology
- Wen-Chi Chou Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- Hung-Chih Hsu Division of Hematology & Oncology
- 余紹銘 Division of Hematology & Oncology
- 陳宏吉 Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
- Cheng-Lung Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
164 participants
